Increased IL-22 level in allergic rhinitis significantly correlates with clinical severity

American Journal of Rhinology and Allergy

Volumn 28, Issue 6, 2014, Pages e197-e201

  Tang, Jun ^a   Xiao, Ping ^a   Luo, Xi ^b   Bai, Jing ^a   Xia, Wentong ^b   Chen, Weixiong ^a   Li, Jian ^b   Yu, Qingqing ^a   Shi, Sisi ^a   Xu, Yuxia ^a   Mou, Zhonglin ^c   Wang, Yuejian ^a   Li, Huabin ^b  

^a THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 22; HOUSE DUST ALLERGEN; INTERLEUKIN 9; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ALLERGIC RHINITIS; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; MALE; NOSE OBSTRUCTION; PRURITUS; RHINORRHEA; SMOKING; SNEEZING; SYMPTOM; ANIMAL; BLOOD; DISEASE COURSE; GENETICS; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; VISUAL ANALOG SCALE; YOUNG ADULT;

ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-17; INTERLEUKIN-9; INTERLEUKINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NASAL OBSTRUCTION; RHINITIS, ALLERGIC; T-LYMPHOCYTES, HELPER-INDUCER; VISUAL ANALOG SCALE; YOUNG ADULT;

EID: 84918525317     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2014.28.4088     Document Type: Article

References (23)

1. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
2. Greiner AN, Hellings PW, Rotiroti G, and Scadding GK. Allergic rhinitis. Lancet 378:2112-2122, 2011.
3. Bacchetta R, Gambineri E, and Roncarolo MG. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 120:227-235, 2007.
4. Lloyd CM, and Saglani S. T cells in asthma: Influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol 131:1267-1274, 2013.
5. Akdis CA, and Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 127:18-27, 2011.
6. Akdis M, Palomares O, van de Veen W, et al. TH17 and TH22 cells: A confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol 129:1438-1449, 2012.
7. Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023-1032, 2008.
8. Ciprandi G, De Amici M, Murdaca G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64: 1375-1378, 2009.
9. Tang H, Wang H, Bai J, et al.; Nasal Health Group and China. Sensitivity of MUC5AC to topical corticosteroid is negatively associated with interleukin-17A in patients with allergic rhinitis. Am J Rhinol Allergy 26:359-364, 2012.
10. Sonnenberg GF, Nair MG, Kirn TJ, et al. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 207:1293-1305, 2010.
11. Farfariello V, Amantini C, Nabissi M, et al. IL-22 mRNA in peripheral blood mononuclear cells from allergic rhinitic and asthmatic pediatric patients. Pediatr Allergy Immunol 22:419-423, 2011.
12. Zhu J, Cao Y, Li K, et al. Increased expression of aryl hydrocarbon receptor and interleukin 22 in patients with allergic asthma. Asian Pac J Allergy Immunol 29:266-272, 2011.
13. Maddur MS, Miossec P, Kaveri SV, and Bayry J. Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181:8-18, 2012.
14. Oboki K, Ohno T, Saito H, and Nakae S. Th17 and allergy. Allergol Int 57:121-134, 2008.
15. Jiang XD, Li GY, Li L, et al. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 25:e171-e175, 2011.
16. Wang M, Zhang W, Shang J, et al. Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis. Clin Exp Allergy 43:956-966, 2013.
17. Quan SH, Zhang YL, Han DH, et al. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model. Ann Allergy Asthma Immunol 108:342-350, 2012.
18. Lajoie S, Lewkowich IP, Suzuki Y, et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11:928-935, 2010.
19. Zhao Y, Yang J, Gao YD, and Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 151:297-307, 2010.
20. Nakagome K, Imamura M, Kawahata K, et al. High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J Immunol 187:5077-5089, 2011.
21. Pennino D, Bhavsar PK, Effner R, et al. IL-22 suppresses IFN-γ-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 131:562-570, 2013.
22. Besnard AG, Sabat R, Dumoutier L, et al. Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med 183:1153-1163, 2011.
23. Takahashi K, Hirose K, Kawashima S, et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol 128:1067-1076.e1-6, 2011.